{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By STEVEN DAVIDOFF SOLOMON", "person": [{"middlename": "Davidoff", "firstname": "Steven", "role": "reported", "lastname": "SOLOMON", "rank": 1, "organization": ""}]}, "abstract": null, "type_of_material": "News", "word_count": "1058", "keywords": [{"rank": "1", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Suits and Litigation (Civil)", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Abbott Laboratories", "is_major": "N", "name": "organizations"}, {"rank": "4", "value": "St Jude Medical Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "Delaware courts have been tough to convince on material adverse change clauses, but this is one deal where the buyer might very well prevail.", "pub_date": "2016-12-08T00:34:44+0000", "document_type": "article", "source": "The New York Times", "snippet": "Delaware courts have been tough to convince on material adverse change clauses, but this is one deal where the buyer might very well prevail....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/12/07/business/dealbook/abbott-laboratories-alere-mac-clause.html", "slideshow_credits": null, "blog": [], "_id": "5848aaa795d0e03926074bfa", "headline": {"main": "In Abbott\u2019s Bid to Halt Purchase of Alere, the MAC Makes a Comeback", "content_kicker": "Deal Professor"}}